Four facts about BCA's Advanced Therapies Network
- BCA centers generate >$3B in revenue annually managing >50% of the country’s supply of blood and blood components from >500 facilities owned by ~65 centers in 43 states supplying biomaterials from >3.5 million annual donors to thousands of hospitals.
- BCA additionally represents access to 7 cord blood banks, almost 60 tissue banks and organ procurement organizations, and 16 IRL testing facilities in 13 states.
- BCA itself manages >$1B in transactions generated through purchasing/selling contracts it has negotiated and manages on behalf of its members.
- Specifically on the advanced therapies side, in 2021 BCA sites performed >10,000 cell therapy (autologous & healthy donor) collections + >20,000 therapeutic apheresis procedures on ~380 Optia devices at >50 locations. Many of these sites have or have already planned in the budget to incorporate or expand cryopreservation capabilities.
